000843668 000__ 05474cam\a2200505Ii\4500
000843668 001__ 843668
000843668 005__ 20230306144904.0
000843668 006__ m\\\\\o\\d\\\\\\\\
000843668 007__ cr\cn\nnnunnun
000843668 008__ 180621s2018\\\\si\\\\\\ob\\\\000\0\eng\d
000843668 020__ $$a9789811302893$$q(electronic book)
000843668 020__ $$a9811302898$$q(electronic book)
000843668 020__ $$z9789811302886
000843668 035__ $$aSP(OCoLC)on1041152811
000843668 035__ $$aSP(OCoLC)1041152811
000843668 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dEBLCP$$dOCLCA$$dOCLCF$$dUAB
000843668 049__ $$aISEA
000843668 050_4 $$aRM315
000843668 08204 $$a615.78$$223
000843668 1000_ $$aAmritpal Singh,$$d1971-$$eauthor.
000843668 24510 $$aPharmacotherapeutic Potential of Natural Products in Neurological Disorders /$$cAmritpal Singh Saroya, Jaswinder Singh.
000843668 264_1 $$aSingapore :$$bSpringer,$$c[2018]
000843668 264_4 $$c©2018
000843668 300__ $$a1 online resource.
000843668 336__ $$atext$$btxt$$2rdacontent
000843668 337__ $$acomputer$$bc$$2rdamedia
000843668 338__ $$aonline resource$$bcr$$2rdacarrier
000843668 504__ $$aIncludes bibliographical references.
000843668 5050_ $$aIntro; Contents; About the Authors; 1: Introduction to Herbal Medicine; 1.1 Some Basic Definitions; 1.2 History of Herbal Medicine; 1.3 Renaissance of Herbal Medicine; 1.4 Herbal Glossary; 2: Medicinal Herbs Used in Herbal Medicine for Neurological Disorders; 2.1 Albizia julibrissin Baker (Fabaceae); 2.2 Acorus gramineus Sol. Aiton (Acoraceae); 2.3 Acorus tatarinowii Schott (Acoraceae); 2.4 Amphilophium crucigerum (L.) L.G.Lohmann (Bignoniaceae); 2.5 Galphimia glauca Cav. (Malpighiaceae); 2.6 Hypoxis hemerocallidea Fisch. & C. A. Mey. (Hypoxidaceae)
000843668 5058_ $$a2.7 Litsea glaucescens Kunth (Lauraceae)2.8 Leonurus sibiricus L. (Lamiaceae); 2.9 Melissa officinalis L. (Lamiaceae); 2.10 Nepeta cataria L. (Lamiaceae); 2.11 Nepeta hindostana (Roth) Haines (Lamiaceae); 2.12 Petiveria alliacea L.; 2.13 Salvia guaranitica St. Hil. (Lamiaceae); 2.14 Sceletium tortuosum (L.) N.E. Brown (Aizoaceae); 2.15 Sorbus alnifolia (Sieb. et Zucc.) K. Koch (Rosaceae); 2.16 Stereospermum kunthianum Cham. (Bignoniaceae); 2.17 Tilia tomentosa Moench (Tiliaceae); 2.18 Verbena officinalis L. (Verbenaceae); References
000843668 5058_ $$a3: Neuropharmacology of Genus Hypericum: Hypericin and Hyperforin3.1 Hypericum perforatum Linn. (Guttiferae); 3.2 Habitat; 3.3 Botany; 3.4 Traditional Use in Treatment of Diseases of the Nervous System; 3.5 Chemistry; 3.5.1 Napthodianthrones; 3.5.2 Acylphloroglucinols; 3.5.3 Flavonoids; 3.5.4 Flavanols; 3.5.5 Xanthones and Sterols (Mathis and Ourisson 1964); 3.5.6 Terpenoids; 3.6 Neuropharmacology of H. perforatum Extract; 3.6.1 Non-clinical Studies; 3.6.1.1 Antidepressant Activity; 3.6.1.2 Anxiolytic Activity; 3.6.1.3 Anti-dementia Activity; 3.6.1.4 Antistress Activity
000843668 5058_ $$a3.6.1.5 Neuroprotective Activity3.7 Neuropharmacology of Hypericin; 3.7.1 Non-clinical; 3.7.2 Clinical; 3.8 Neuropharmacology of Pseudohypericin; 3.9 Neuropharmacology of H. perforatum Xanthones; 3.10 Neuropharmacology of H. perforatum Flavonoids; 3.11 Neuropharmacology of Hyperforin; 3.11.1 Non-clinical; 3.11.2 Clinical; 3.12 Neuropharmacology of Adhyperforin; 3.13 Clinical Pharmacology of H. perforatum Extract; 3.13.1 Clinical Trials in Depression; 3.13.1.1 Mild to Moderate Depression; 3.13.1.2 Severe Major Depression; 3.13.2 Hypericum and Seasonal Affective Disorder (SAD)
000843668 5058_ $$a3.13.3 Hypericum and Obsessive-Compulsive Disorder (OCD)3.13.4 Comparative Trials with Synthetic Drugs; 3.13.4.1 Hypericum Extract vs Maprotiline; 3.13.4.2 Hypericum Extract Versus Imipramine; 3.13.4.3 Hypericum Extract Versus Amitriptyline; 3.13.4.4 Hypericum Extract Versus Fluoxetine; 3.13.4.5 Hypericum Extract Versus Sertraline; 3.13.4.6 Hypericum Extract Versus Citalopram; 3.13.4.7 Hypericum Extract Versus Paroxetine; 3.14 Neuropharmacology of Other Hypericum Species; 3.14.1 Hypericum calycinum L.; 3.14.2 Hypericum caprifoliatum Cham. & Schltdl.
000843668 506__ $$aAccess limited to authorized users.
000843668 520__ $$a"Natural Products have always played a pivotal role as sources for drug lead compounds. This book is aimed at providing inside purview of the scope of natural products (including herbal and marine) in the possible treatment of neurological disorders. The book explains pre-clinical neuropharmacological investigations done on herbs including Bacopa monnieri, Hypericum perforatum, Passiflora incarnata, Scutellaria baicalensis and Piper methysticum. It provides a comprehensive overview of the role of phytoconstituents like huperzine, curcumin, Salvinorin A, bioflavonoids, sulforaphane, tanshinone IIA, tetramethylpyrazine, tetrahydrocannabinol, and cannabidiol in the treatment of neurological disorders. The book provides a modern concept of herbal medications, neuropharmacology of marine bioactive products and Ayurvedic formulations, herbal drugs with abuse potential and neurotoxic mycotoxins."--$$cProvided by publisher.
000843668 588__ $$aOnline resource; title from PDF title page (viewed June 25, 2018).
000843668 650_0 $$aNeuropharmacology.
000843668 650_0 $$aNatural products$$xTherapeutic use.
000843668 650_0 $$aNervous system$$xDiseases$$xChemotherapy.
000843668 7001_ $$aJaswinder Singh,$$d1949-$$eauthor.
000843668 852__ $$bebk
000843668 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-13-0289-3$$zOnline Access$$91397441.1
000843668 909CO $$ooai:library.usi.edu:843668$$pGLOBAL_SET
000843668 980__ $$aEBOOK
000843668 980__ $$aBIB
000843668 982__ $$aEbook
000843668 983__ $$aOnline
000843668 994__ $$a92$$bISE